General medical practice activities
NEVRO ARENDAL AS
Revenue 2024
NOK 11.0m
Operating profit
NOK 7.8m
Equity
NOK 2.4m
Incorporated
2017
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.32
Equity ratio
27.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 71.0% | |
| Net margin (%%) | 55.2% | |
| Return on assets (%%) | 88.7% | |
| Likviditet | ||
| Current ratio | 0.32 | |
| Working capital | −4.3m | |
| Soliditet | ||
| Equity ratio (%%) | 27.6% | |
| Debt-to-equity ratio | 2.62 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.